Vitale, A. Et Al. 2023. CANAKINUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN STILL'S DISEASE AND DIFFERENCES BETWEEN THE SYSTEMIC AND THE CHRONICARTICULAR COURSES: REAL-LIFE EXPERIENCE FROM THE INTERNATIONAL AIDA REGISTRY. European Congress of Rheumatology (EULAR) , (Milan, Italy), 1404-1405.

Vitale, A., Caggiano, V., Maggio, M. C., Lopalco, G., Emmi, G., Sota, J., ... La Torre, F.(2023). CANAKINUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN STILL'S DISEASE AND DIFFERENCES BETWEEN THE SYSTEMIC AND THE CHRONICARTICULAR COURSES: REAL-LIFE EXPERIENCE FROM THE INTERNATIONAL AIDA REGISTRY . European Congress of Rheumatology (EULAR) (pp.1404-1405). Milan, Italy

Vitale, A. Et Al. "CANAKINUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN STILL'S DISEASE AND DIFFERENCES BETWEEN THE SYSTEMIC AND THE CHRONICARTICULAR COURSES: REAL-LIFE EXPERIENCE FROM THE INTERNATIONAL AIDA REGISTRY," European Congress of Rheumatology (EULAR), Milan, Italy, 2023

Vitale, A. Et Al. "CANAKINUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN STILL'S DISEASE AND DIFFERENCES BETWEEN THE SYSTEMIC AND THE CHRONICARTICULAR COURSES: REAL-LIFE EXPERIENCE FROM THE INTERNATIONAL AIDA REGISTRY." European Congress of Rheumatology (EULAR) , Milan, Italy, pp.1404-1405, 2023

Vitale, A. Et Al. (2023) . "CANAKINUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN STILL'S DISEASE AND DIFFERENCES BETWEEN THE SYSTEMIC AND THE CHRONICARTICULAR COURSES: REAL-LIFE EXPERIENCE FROM THE INTERNATIONAL AIDA REGISTRY." European Congress of Rheumatology (EULAR) , Milan, Italy, pp.1404-1405.

@conferencepaper{conferencepaper, author={A. Vitale Et Al. }, title={CANAKINUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN STILL'S DISEASE AND DIFFERENCES BETWEEN THE SYSTEMIC AND THE CHRONICARTICULAR COURSES: REAL-LIFE EXPERIENCE FROM THE INTERNATIONAL AIDA REGISTRY}, congress name={European Congress of Rheumatology (EULAR)}, city={Milan}, country={Italy}, year={2023}, pages={1404-1405} }